SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-033652
Filing Date
2013-02-01
Accepted
2013-02-01 08:59:36
Documents
4
Period of Report
2013-02-25
Effectiveness Date
2013-02-01

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d469192ddef14a.htm DEF 14A 146338
2 GRAPHIC g469192g16d04.gif GRAPHIC 52926
3 GRAPHIC g469192g28z04.gif GRAPHIC 39943
4 GRAPHIC g469192g95l79.jpg GRAPHIC 7061
  Complete submission text file 0001193125-13-033652.txt   285704
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22873 | Film No.: 13564831
SIC: 2835 In Vitro & In Vivo Diagnostic Substances